Acumen Total Assets vs Inventory Analysis

ABOS Stock  USD 2.94  0.04  1.34%   
Acumen Pharmaceuticals financial indicator trend analysis is way more than just evaluating Acumen Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Acumen Pharmaceuticals is a good investment. Please check the relationship between Acumen Pharmaceuticals Total Assets and its Inventory accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.

Total Assets vs Inventory

Total Assets vs Inventory Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Acumen Pharmaceuticals Total Assets account and Inventory. At this time, the significance of the direction appears to have pay attention.
The correlation between Acumen Pharmaceuticals' Total Assets and Inventory is -0.84. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Inventory in the same time period over historical financial statements of Acumen Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Acumen Pharmaceuticals' Total Assets and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Acumen Pharmaceuticals are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Total Assets i.e., Acumen Pharmaceuticals' Total Assets and Inventory go up and down completely randomly.

Correlation Coefficient

-0.84
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of Acumen Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Acumen Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Inventory

Most indicators from Acumen Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.Selling General Administrative is likely to gain to about 19.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 83.5 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Income84K2.4M8.2M8.6M
Net Interest Income84K2.4M8.2M8.6M

Acumen Pharmaceuticals fundamental ratios Correlations

0.890.920.990.96-0.73-0.950.940.870.870.02-0.881.00.540.75-0.11-0.840.920.870.080.991.01.00.67-0.56-0.73
0.891.00.830.79-0.55-0.880.870.720.820.05-0.910.890.740.810.3-0.570.670.830.480.840.890.880.74-0.61-0.74
0.921.00.860.82-0.58-0.90.890.750.830.07-0.910.910.720.810.23-0.620.710.860.430.870.910.90.74-0.61-0.76
0.990.830.860.97-0.76-0.940.940.880.850.04-0.830.990.450.7-0.25-0.90.950.86-0.061.00.990.990.62-0.51-0.72
0.960.790.820.97-0.75-0.960.930.90.90.0-0.860.960.510.7-0.28-0.920.950.9-0.110.960.960.970.68-0.65-0.78
-0.73-0.55-0.58-0.76-0.750.63-0.84-0.95-0.410.420.78-0.770.04-0.120.30.63-0.84-0.50.19-0.73-0.77-0.77-0.070.070.57
-0.95-0.88-0.9-0.94-0.960.63-0.93-0.83-0.94-0.170.86-0.95-0.67-0.830.140.87-0.84-0.98-0.05-0.94-0.95-0.94-0.810.750.87
0.940.870.890.940.93-0.84-0.930.940.770.0-0.910.960.440.62-0.16-0.810.870.870.030.930.960.960.56-0.49-0.87
0.870.720.750.880.9-0.95-0.830.940.66-0.29-0.90.90.250.39-0.24-0.760.920.72-0.10.860.90.90.36-0.36-0.72
0.870.820.830.850.9-0.41-0.940.770.660.18-0.770.860.810.92-0.03-0.80.760.930.130.860.860.850.93-0.88-0.71
0.020.050.070.040.00.42-0.170.0-0.290.180.27-0.010.250.43-0.25-0.26-0.190.33-0.160.07-0.01-0.020.39-0.28-0.34
-0.88-0.91-0.91-0.83-0.860.780.86-0.91-0.9-0.770.27-0.9-0.58-0.61-0.170.6-0.8-0.78-0.32-0.83-0.9-0.89-0.590.550.73
1.00.890.910.990.96-0.77-0.950.960.90.86-0.01-0.90.520.72-0.13-0.840.930.870.060.991.01.00.65-0.54-0.75
0.540.740.720.450.510.04-0.670.440.250.810.25-0.580.520.920.46-0.330.280.720.580.480.510.50.95-0.9-0.52
0.750.810.810.70.7-0.12-0.830.620.390.920.43-0.610.720.920.17-0.620.510.870.340.730.710.710.98-0.87-0.64
-0.110.30.23-0.25-0.280.30.14-0.16-0.24-0.03-0.25-0.17-0.130.460.170.59-0.35-0.150.98-0.22-0.13-0.150.16-0.090.2
-0.84-0.57-0.62-0.9-0.920.630.87-0.81-0.76-0.8-0.260.6-0.84-0.33-0.620.59-0.87-0.850.42-0.89-0.84-0.85-0.590.560.74
0.920.670.710.950.95-0.84-0.840.870.920.76-0.19-0.80.930.280.51-0.35-0.870.72-0.210.940.930.940.46-0.41-0.58
0.870.830.860.860.9-0.5-0.980.870.720.930.33-0.780.870.720.87-0.15-0.850.720.040.860.870.860.86-0.82-0.92
0.080.480.43-0.06-0.110.19-0.050.03-0.10.13-0.16-0.320.060.580.340.980.42-0.210.04-0.030.060.040.3-0.20.02
0.990.840.871.00.96-0.73-0.940.930.860.860.07-0.830.990.480.73-0.22-0.890.940.86-0.030.990.990.65-0.53-0.72
1.00.890.910.990.96-0.77-0.950.960.90.86-0.01-0.91.00.510.71-0.13-0.840.930.870.060.991.00.64-0.54-0.74
1.00.880.90.990.97-0.77-0.940.960.90.85-0.02-0.891.00.50.71-0.15-0.850.940.860.040.991.00.64-0.54-0.74
0.670.740.740.620.68-0.07-0.810.560.360.930.39-0.590.650.950.980.16-0.590.460.860.30.650.640.64-0.95-0.64
-0.56-0.61-0.61-0.51-0.650.070.75-0.49-0.36-0.88-0.280.55-0.54-0.9-0.87-0.090.56-0.41-0.82-0.2-0.53-0.54-0.54-0.950.64
-0.73-0.74-0.76-0.72-0.780.570.87-0.87-0.72-0.71-0.340.73-0.75-0.52-0.640.20.74-0.58-0.920.02-0.72-0.74-0.74-0.640.64
Click cells to compare fundamentals

Acumen Pharmaceuticals Account Relationship Matchups

Pair Trading with Acumen Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acumen Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Acumen Stock

  0.82EQ EquilliumPairCorr

Moving against Acumen Stock

  0.44VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Acumen Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acumen Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acumen Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acumen Pharmaceuticals to buy it.
The correlation of Acumen Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acumen Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acumen Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acumen Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Acumen Pharmaceuticals is a strong investment it is important to analyze Acumen Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Acumen Pharmaceuticals' future performance. For an informed investment choice regarding Acumen Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Acumen Stock analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Revenue Per Share
0.033
Return On Assets
(0.15)
Return On Equity
(0.23)
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acumen Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.